Alazzouzi, H., Suriano, G., Guerra, A., Plaja, A., Espín, E., Armengol, M., . . . Arango, D. (2007). Tumour selection advantage of non‐dominant negative P53 mutations in homozygotic MDM2‐SNP309 colorectal cancer cells. BMJ Group.
Chicago ZitierstilAlazzouzi, Hafid, et al. Tumour Selection Advantage of Non‐dominant Negative P53 Mutations in Homozygotic MDM2‐SNP309 Colorectal Cancer Cells. BMJ Group, 2007.
MLA ZitierstilAlazzouzi, Hafid, et al. Tumour Selection Advantage of Non‐dominant Negative P53 Mutations in Homozygotic MDM2‐SNP309 Colorectal Cancer Cells. BMJ Group, 2007.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.